Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.

Hulse KE, Reefer AJ, Engelhard VH, Satinover SM, Patrie JT, Chapman MD, Woodfolk JA.

J Allergy Clin Immunol. 2008 Mar;121(3):756-762.e4. Epub 2007 Dec 20.

PMID:
18086491
2.

Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor.

Hulse KE, Reefer AJ, Engelhard VH, Patrie JT, Ziegler SF, Chapman MD, Woodfolk JA.

J Allergy Clin Immunol. 2010 Jan;125(1):247-56.e1-8. doi: 10.1016/j.jaci.2009.10.027.

3.

Targeting allergen to Fc gammaRI: a strategy to treat allergic disease?

Hulse KE, Woodfolk JA.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):547-52. doi: 10.1097/ACI.0b013e32831665d2. Review.

4.

A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.

Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J, Woodfolk JA.

J Immunol. 2004 Mar 1;172(5):2763-72.

5.

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.

Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS.

J Allergy Clin Immunol. 2003 Jan;111(1):155-61.

PMID:
12532112
6.

High-level expression of immunoreactive recombinant cat allergen (Fel d 1): Targeting to antigen-presenting cells.

Vailes LD, Sun AW, Ichikawa K, Wu Z, Sulahian TH, Chapman MD, Guyre PM.

J Allergy Clin Immunol. 2002 Nov;110(5):757-62.

PMID:
12417885
7.

A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.

Niespodziana K, Focke-Tejkl M, Linhart B, Civaj V, Blatt K, Valent P, van Hage M, Grönlund H, Valenta R.

J Allergy Clin Immunol. 2011 Jun;127(6):1562-70.e6. doi: 10.1016/j.jaci.2011.02.004. Epub 2011 Mar 16.

PMID:
21411130
8.

Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization.

Schroeder JT, Bieneman AP, Chichester KL, Hamilton RG, Xiao H, Saini SS, Liu MC.

J Allergy Clin Immunol. 2010 Apr;125(4):896-901.e6. doi: 10.1016/j.jaci.2009.10.021. Epub 2010 Feb 4.

PMID:
20132969
9.

Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.

Renand A, Archila LD, McGinty J, Wambre E, Robinson D, Hales BJ, Thomas WR, Kwok WW.

J Allergy Clin Immunol. 2015 Dec;136(6):1627-1635.e13. doi: 10.1016/j.jaci.2015.07.031. Epub 2015 Sep 11.

10.

Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.

Zaleska A, Eiwegger T, Soyer O, van de Veen W, Rhyner C, Soyka MB, Bekpen C, Demiröz D, Treis A, Söllner S, Palomares O, Kwok WW, Rose H, Senti G, Kündig TM, Ozoren N, Jutel M, Akdis CA, Crameri R, Akdis M.

Allergy. 2014 Sep;69(9):1162-70. doi: 10.1111/all.12461. Epub 2014 Jul 12. Erratum in: Allergy. 2016 Jan;71(1):129.

11.

IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.

Hales BJ, Chai LY, Hazell L, Elliot CE, Stone S, O'Neil SE, Smith WA, Thomas WR.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):656-65.e1-5. doi: 10.1016/j.jaip.2013.08.008. Epub 2013 Oct 31.

PMID:
24565714
13.

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.

Curin M, Weber M, Thalhamer T, Swoboda I, Focke-Tejkl M, Blatt K, Valent P, Marth K, Garmatiuk T, Grönlund H, Thalhamer J, Spitzauer S, Valenta R.

Clin Exp Allergy. 2014 Jun;44(6):882-94. doi: 10.1111/cea.12294.

14.

Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.

Mark PG, Segal DB, Dallaire ML, Garman RD.

Clin Exp Allergy. 1996 Nov;26(11):1316-28.

PMID:
8955581
15.

Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.

Pène J, Desroches A, Paradis L, Lebel B, Farce M, Nicodemus CF, Yssel H, Bousquet J.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):571-8.

PMID:
9802364
16.
17.

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.

Senti G, Crameri R, Kuster D, Johansen P, Martinez-Gomez JM, Graf N, Steiner M, Hothorn LA, Grönlund H, Tivig C, Zaleska A, Soyer O, van Hage M, Akdis CA, Akdis M, Rose H, Kündig TM.

J Allergy Clin Immunol. 2012 May;129(5):1290-6. doi: 10.1016/j.jaci.2012.02.026. Epub 2012 Mar 30.

PMID:
22464647
18.
19.

Dendritic cell-derived exosomes carry the major cat allergen Fel d 1 and induce an allergic immune response.

Vallhov H, Gutzeit C, Hultenby K, Valenta R, Grönlund H, Scheynius A.

Allergy. 2015 Dec;70(12):1651-5. doi: 10.1111/all.12701. Epub 2015 Aug 25.

PMID:
26198793
20.

Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.

Grundström J, Neimert-Andersson T, Kemi C, Nilsson OB, Saarne T, Andersson M, van Hage M, Gafvelin G.

Int Arch Allergy Immunol. 2012;157(2):136-46. doi: 10.1159/000327546. Epub 2011 Oct 5.

PMID:
21985799

Supplemental Content

Support Center